Evidence map›Paper›PMID 27312739›Full record

ArticleThe Lancet. Neurology2016

Cerebrovascular pathology and Alzheimer's disease.

Peter T Nelson

Abstract readComment
PubMed Full text at PMC Publisher
In one paragraph

Article in The Lancet. Neurology, 2016. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

5 · Who and what money

Authors and funding

1 author.

Peter T NelsonUniversity of Kentucky, Lexington, KY 40536-0230, USA. Electronic address: pnels2@email.uky.edu.

Funding

University of Kentucky Alzheimer's Disease Core Center - Biomarker CoreP30AG028383 · NIA · UNIVERSITY OF KENTUCKY · PI GOLD, BRIAN TIMOTHY, VAN ELDIK, LINDA J · 2006 to 2020
$23.3M
Early Detection and Prevention of Mild Cognitive Impairment due to Cerebrovascular DiseaseR01NR014189 · NINR · UNIVERSITY OF KENTUCKY · PI JICHA, GREGORY A, MOSER, DEBRA KAY · 2012 to 2016
$2.0M
Modulation of microRNA pathways by gemfibrozil in predementia Alzheimer diseaseR01AG042419 · NIA · UNIVERSITY OF KENTUCKY · PI JICHA, GREGORY A, NELSON, PETER T. · 2013 to 2016
$1.6M
NIA NIH HHS P30 AG028383NIA NIH HHS R01 AG042419NINR NIH HHS R01 NR014189
6 · The paper itself

Abstract

PubMed holds no abstract for this paper.

Indexed as

Alzheimer DiseaseDementia, VascularCerebrovascular DisordersHumans

Identifiers

PMID27312739
PMCPMC5327818

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.